Overall rank by patents
#8,446
of 50,000 tracked assignees
USPTO PatentsView assignee record - 38 granted patents across 15 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;).
The verdict
According to USPTO PatentsView, Musculoskeletal ranks #8,446 of 50,000 tracked US assignees by granted-patent volume, with 38 patents across 15 technology areas.
USPTO PatentsView assignee plate
Corpus R8446 · US Corporation #8,446 · 38 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Micronas Gmbh (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Copan Italia S p a · near
40 score
Kwik Tek · near
40 score
Musculoskeletal Tran… · this assignee
40 score
Nippon Steel & Sumik… · near
40 score
Saurer Spinning Solu… · near
40 score
3D Lighting Innovati… · lowest
7 score
What this shows Musculoskeletal Transplant Foundation stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-RICH, TYPE-USCORP, VEL-SURGE, BOOK-FULL. Volume places it #8,446 of 50,000; Innovation Score 40.1/100 sits in the top 37% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Micronas Gmbh (±0 grants).
Musculoskeletal Transplant Foundation has been granted 38 US utility patents between 2015 and 2025, placing Musculoskeletal Transplant Foundation at #8,446 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.4 claims per patent with primary concentration in A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;). As a US Corporation, Musculoskeletal Transplant Foundation is one of the more focused assignees in the PatentsView dataset. By volume, Musculoskeletal sits between Micronas Gmbh (38 patents, rank #8,442) and Nippon Chemiphar Co., Ltd. (38 patents, rank #8,450) - the closest US assignees by grant volume. The composite Innovation Score of 40.1/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 27 grants, compared with 9 in the 2015–2019 window, a +200% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Musculoskeletal Transplant Foundation's 14.4 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 15 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Micronas GmbH
38 patents
Mikron Industries, Inc.
38 patents
Minimax GmbH & Co KG
38 patents
Morpho Detection, LLC
38 patents
NALUX CO., LTD.
38 patents
NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
38 patents
NIDEC COPAL ELECTRONICS CORPORATION
38 patents
NIPPON CHEMIPHAR CO., LTD.
38 patents
Musculoskeletal Transplant Foundation
38 patents
What this shows Musculoskeletal holds 38 patents at rank #8,446, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #8,446 in granted patent volume.
Other assignees with the most granted patents in Musculoskeletal's primary technology class.
Two PlainPatent-derived peer sets for Musculoskeletal, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (40 here).
Musculoskeletal's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 37% higher than 63% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 5.3% |
| 2016 | 1 | 2.6% |
| 2018 | 3 | 7.9% |
| 2019 | 3 | 7.9% |
| 2020 | 7 | 18.4% |
| 2021 | 7 | 18.4% |
| 2022 | 4 | 10.5% |
| 2023 | 7 | 18.4% |
| 2024 | 2 | 5.3% |
| 2025partial year | 2 | 5.3% |
Top 15 of 15 technology areas
Overall rank by patents
#8,446
of 50,000 tracked assignees
40.1 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.